Endocardial and epicardial mapping and catheter ablation of post myocardial infarction ventricular tachycardia

2010 ◽  
Vol 28 (2) ◽  
pp. 137-145 ◽  
Author(s):  
Mauricio Arruda ◽  
Tamer Fahmy ◽  
Luciana Armaganijan ◽  
Luigi Di Biase ◽  
Dimpi Patel ◽  
...  
2018 ◽  
Vol 28 (6) ◽  
pp. 890-893
Author(s):  
Hisaaki Komaki ◽  
Takashi Nakashima ◽  
Shinya Minatoguchi

AbstractIn some patients with Kawasaki disease, a prior myocardial infarction causes ventricular tachycardia in the chronic post-myocardial infarction phase. We report the case of a 41-year-old man with symptomatic and haemodynamically unstable ventricular tachycardia in whom substrate ablation was performed for the ventricular tachycardia before insertion of an implantable cardioverter-defibrillator.


2010 ◽  
Vol 19 ◽  
pp. S113
Author(s):  
J. Pouliopoulos ◽  
G. Sivagangabalan ◽  
W. Chik ◽  
K. Huang ◽  
J. Lu ◽  
...  

1998 ◽  
Vol 82 (4) ◽  
pp. 429-432 ◽  
Author(s):  
David J. Callans ◽  
Erica Zado ◽  
Brian H. Sarter ◽  
David Schwartzman ◽  
Charles D. Gottlieb ◽  
...  

2018 ◽  
Vol 18 (3) ◽  
pp. 91-94 ◽  
Author(s):  
Advithi Rangaraju ◽  
Shuba Krishnan ◽  
G. Aparna ◽  
Satish Sankaran ◽  
Ashraf U. Mannan ◽  
...  

Circulation ◽  
2020 ◽  
Vol 142 (Suppl_3) ◽  
Author(s):  
Raj Patel ◽  
Dipesh Ludhwani ◽  
Harsh P Patel ◽  
Samarthkumar J Thakkar ◽  
Love shah ◽  
...  

Introduction: Ventricular tachycardia (VT) is a significant cause of morbidity and mortality in patients with heart failure with reduced ejection fraction (HFrEF). Hypothesis: Data on efficacy, safety, and outcomes of catheter ablation for VT in HFrEF have not been studied well. Methods: The 2002-2014 Nationwide Inpatient Sample (NIS) was used to identify all hospitalizations with a principle diagnosis of VT (International Classification of Diseases, Ninth Edition, Clinical Modification [ICD-9-CM] code 427.1) and a secondary diagnosis of HFrEF. Patients who underwent catheter ablation were identified using ICD-9-CM procedure code 37.34. Results: Of 228,557 patients with HFrEF & VT, 5845 (2.56%) underwent catheter ablation. The prevalence of Diabetes Mellitus (DM) and Chronic Kidney disease (CKD) was higher in the reference population contrary to a higher prevalence of prior myocardial infarction (MI), coronary bypass and AICD in those undergoing CA. The frequency of complications in the ablation group was 19.47%, the most common being post-operative hemorrhage (8.3%). This was followed by myocardial infarction (5.34%), pericardial complications (3.38%), and neurological complications (2.14%) (Figure 1.). The odds of in-hospital mortality were lower in the CA group compared to the reference group (5.08% vs 9.42%, p<0.05). Conclusions: Compared to medical therapy, VT ablation in HFrEF is associated with lower mortality though with significant complication rate. This suggests a need for future studies identifying the safety measures in VT ablations and instituting appropriate interventions to improve overall VT ablation outcomes.


Author(s):  
Hein Heidbuchel ◽  
Mattias Duytschaever ◽  
Haran Burri

This case discusses substrate modification for post-myocardial infarction ventricular tachycardia


2019 ◽  
Vol 40 (35) ◽  
pp. 2940-2949 ◽  
Author(s):  
Konstantinos A Gatzoulis ◽  
Dimitrios Tsiachris ◽  
Petros Arsenos ◽  
Christos-Konstantinos Antoniou ◽  
Polychronis Dilaveris ◽  
...  

Abstract Aims Sudden cardiac death (SCD) annual incidence is 0.6–1% in post-myocardial infarction (MI) patients with left ventricular ejection fraction (LVEF)≥40%. No recommendations for implantable cardioverter-defibrillator (ICD) use exist in this population. Methods and results We introduced a combined non-invasive/invasive risk stratification approach in post-MI ischaemia-free patients, with LVEF ≥ 40%, in a multicentre, prospective, observational cohort study. Patients with at least one positive electrocardiographic non-invasive risk factor (NIRF): premature ventricular complexes, non-sustained ventricular tachycardia, late potentials, prolonged QTc, increased T-wave alternans, reduced heart rate variability, abnormal deceleration capacity with abnormal turbulence, were referred for programmed ventricular stimulation (PVS), with ICDs offered to those inducible. The primary endpoint was the occurrence of a major arrhythmic event (MAE), namely sustained ventricular tachycardia/fibrillation, appropriate ICD activation or SCD. We screened and included 575 consecutive patients (mean age 57 years, LVEF 50.8%). Of them, 204 (35.5%) had at least one positive NIRF. Forty-one of 152 patients undergoing PVS (27–7.1% of total sample) were inducible. Thirty-seven (90.2%) of them received an ICD. Mean follow-up was 32 months and no SCDs were observed, while 9 ICDs (1.57% of total screened population) were appropriately activated. None patient without NIRFs or with NIRFs but negative PVS met the primary endpoint. The algorithm yielded the following: sensitivity 100%, specificity 93.8%, positive predictive value 22%, and negative predictive value 100%. Conclusion The two-step approach of the PRESERVE EF study detects a subpopulation of post-MI patients with preserved LVEF at risk for MAEs that can be effectively addressed with an ICD. Clinicaltrials.gov identifier NCT02124018


Sign in / Sign up

Export Citation Format

Share Document